Baltimore, Sunogel Biotechnologies, Inc. (“Sunogel” or “the Company”), a leader in deep dermal wound healing research, committed to scientific excellence and patient care presents at the 2017 Hello Tomorrow Global Challenge finals, Paris. Watch part of the presentation by Dr Guoming Sun, Chief Executive Officer of Sunogel.

Speaking after the event, Dr Sun commented:

“I would like to thank everyone involved at Hello Tomorrow for such a warm welcome. The opportunity to present our research and connect with like-minded people striving to solve the world’s toughest challenges was invaluable.”